ARCHIVES

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Center And Cooperative Group Clinical Trials Approved By NCI

May 27, 2005

Intensive Chemo Equivalent To Transplant For MCL

December 26, 2008

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

Large Study Finds No Survival Benefit Associated With Removal Of Ovaries

January 30, 2009

A Year in Houston: DePinho Reflects on Plans, Conflicts, Controversies—and Lessons Learned

September 7, 2012